DRTS
Income statement / Annual
Last year (2023), Alpha Tau Medical Ltd.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Alpha Tau Medical Ltd.'s net income was -$29.16 M.
See Alpha Tau Medical Ltd.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$1.07 M |
$979,000.00 |
$776,000.00 |
$86,000.00 |
$0.00 |
Gross Profit |
-$1.07 M |
-$979,000.00 |
-$776,000.00 |
-$86,000.00 |
$0.00 |
Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
Research and Development
Expenses |
$27.27 M
|
$20.89 M
|
$11.45 M
|
$7.54 M
|
$6.64 M
|
General & Administrative
Expenses |
$7.33 M
|
$10.27 M
|
$1.86 M
|
$1.41 M
|
$977,000.00
|
Selling & Marketing
Expenses |
$1.92 M
|
$974,000.00
|
$482,000.00
|
$288,000.00
|
$397,000.00
|
Selling, General &
Administrative Expenses |
$9.26 M
|
$11.25 M
|
$2.34 M
|
$1.70 M
|
$1.37 M
|
Other Expenses |
-$72.20 M |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Operating Expenses |
-$35.68 M |
$32.14 M |
$13.79 M |
$9.24 M |
$8.01 M |
Cost And Expenses |
-$35.68 M |
$32.14 M |
$13.79 M |
$9.24 M |
$8.01 M |
Interest Income |
$4.76 M |
$1.79 M |
$211,000.00 |
$613,000.00 |
$776,000.00 |
Interest Expense |
$39,000.00 |
$1.77 M |
$13.27 M |
$217,000.00 |
$0.00 |
Depreciation &
Amortization |
$1.07 M
|
$979,000.00
|
$776,000.00
|
$86,000.00
|
$66,000.00
|
EBITDA |
-$28.03 M
|
-$32.74 M
|
-$13.22 M
|
-$9.16 M
|
-$7.94 M
|
EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
-$64.82 M
|
-$1.61 M
|
-$13.47 M
|
$520,000.00
|
-$308,000.00
|
Income Before Tax |
-$29.14 M |
-$33.74 M |
-$27.26 M |
-$8.72 M |
-$8.32 M |
Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
Income Tax Expense |
$16,000.00 |
$20,000.00 |
$7,000.00 |
$158,000.00 |
$146,000.00 |
Net Income |
-$29.16 M |
-$33.76 M |
-$27.27 M |
-$8.88 M |
-$8.46 M |
Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
EPS |
-0.42 |
-0.53 |
-0.67 |
-0.22 |
-0.13 |
EPS Diluted |
-0.42 |
-0.53 |
-0.67 |
-0.22 |
-0.13 |
Weighted Average Shares
Out |
$69.38 M
|
$63.53 M
|
$40.53 M
|
$40.43 M
|
$67.62 M
|
Weighted Average Shares
Out Diluted |
$69.38 M
|
$63.53 M
|
$40.53 M
|
$40.43 M
|
$67.62 M
|
Link |
|
|
|
|
|